Achieve Life Sciences to present 52-week cytisinicline data at CHEST 2026
Achieve Life Sciences said it will present 52-week cytisinicline efficacy data for smoking and e-cigarette cessation at CHEST 2026.
Achieve Life Sciences said it will present 52-week cytisinicline efficacy data for smoking and e-cigarette cessation at CHEST 2026.